A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2002
10/02/2002	EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002	EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002	EP1244498A2 Combination of trimebutine with an opioid analgesic
10/02/2002	EP1244469A2 Mutant simplex virus for treating unwanted hyperproliferative cell growth
10/02/2002	EP1244466A2 Activation and inhibition of the immune system
10/02/2002	EP1244462A2 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases
10/02/2002	EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002	EP1244459A2 Treatment of drug-resistant human immunodeficiency virus infection
10/02/2002	EP1244457A2 Methods and compositions related to modulators of annexin and cartilage homeostasis
10/02/2002	EP1244456A1 A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
10/02/2002	EP1244455A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/02/2002	EP1244448A2 Novel methods for the treatment and prevention of ileus
10/02/2002	EP1244447A2 Novel methods and compositions involving opioids and antagonists thereof
10/02/2002	EP1244443A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
10/02/2002	EP1244441A1 Use of trimebutine for treating pain
10/02/2002	EP1244438A1 Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
10/02/2002	EP1244437A1 Tertiary amino compounds having opioid receptor affinity
10/02/2002	EP1244436A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis
10/02/2002	EP1244433A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule
10/02/2002	EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002	EP1100803B1 Pyrrolo [2,1-b] [1,3]benzothiazepines with atypical antipsychotic activity
10/02/2002	EP1079840B1 Synergistic composition of inulin and an anti-cancer drug for use in the treatment of cancer
10/02/2002	EP1047450B1 Ace inhibitor-mmp inhibitor combinations
10/02/2002	EP0991414A4 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
10/02/2002	EP0966285B1 Use of (+)mefloquine for the treatment of malaria
10/02/2002	EP0936915B1 Chelating agents and their metal chelates for treating free radicals induced conditions
10/02/2002	EP0841946B1 Methods for treatment of allergic asthma
10/02/2002	EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002	EP0715628B1 Substituted azaindolylidene compounds and process for their preparation
10/02/2002	EP0668933B1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
10/02/2002	EP0651636B1 Chemotherapy for cancer
10/02/2002	DE10115740A1 Zubereitung für die Restenoseprophylaxe Preparation for the prophylaxis of restenosis
10/02/2002	DE10114364A1 Verfahren zur Herstellung von antibiotischen Kompositen A process for producing antibiotic composites
10/02/2002	DE10114245A1 Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung Preparation and Use of an antibiotic / antibiotics preparation
10/02/2002	DE10114244A1 Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung Antibiotic / antibiotics preparation with retarding active ingredient release
10/02/2002	DE10112926A1 Use of sugar phosphate or aminoacid having e.g. transaminase inhibiting activity, for treating tumors and/or sepsis or inducing immunosuppression
10/02/2002	DE10112925A1 Verwendung von Zuckerphosphaten, Zuckerphosphatanalogen, Aminosäuren, Aminosäureanalogen zur Modulation von Transaminasen und/oder der Assoziation p36/Malat Dehydrogenase Use of sugar phosphates, sugar phosphate analogs, amino acids, amino acid analogues for the modulation of transaminases and / or association of p36 / malate dehydrogenase
10/02/2002	DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives
10/02/2002	DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002	DE10112325A1 Lagerstabile Fertiginfusionslösungen des Paracetamols Storage stable finished infusion solutions of paracetamol
10/02/2002	DE10111486A1 Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit Using one or more of neuroactive substances for the treatment of Parkinson's disease
10/02/2002	CN1372594A OX2 receptor homologs
10/02/2002	CN1372570A Modified exendin and exendin agonists
10/02/2002	CN1372476A Pharmaceutical composition
10/02/2002	CN1372475A Combination therapy of angiotension converting enzyme inhibitor and epoxy-steroidal aldosterone anatagonist for treatment of cardiovascular disease
10/02/2002	CN1372471A Treatment of allergic rhinitis
10/02/2002	CN1372465A Antimycotic drug
10/02/2002	CN1371747A Anti-HIV medicine
10/02/2002	CN1371723A Anti-tumor and antiviral medicine and production method thereof
10/01/2002	US6458931 Immunoassay, immunotherapy; cancer; side effect reduction
10/01/2002	US6458851 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
10/01/2002	US6458850 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
10/01/2002	US6458816 Anticancer agents
10/01/2002	US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002	US6458812 Muscarinic antagonists
10/01/2002	US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002	US6458797 Methods for remodeling neuronal and cardiovascular pathways
10/01/2002	US6458790 Substituted piperidines as melanocortin receptor agonists
10/01/2002	US6458777 Methods and compositions for treating and preventing mucositis
10/01/2002	US6458758 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/01/2002	US6458575 Useful in the diagnosis, prevention, and treatment of cancer, autoimmune/inflammatory disorders, and reproductive disorders; screening libraries of peptides and antibodies; purification; amino acid sequences
10/01/2002	US6458572 Phosphatidylglycerophosphate synthase from Staphylococcus aureus
10/01/2002	US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation
10/01/2002	US6458384 Pharmaceutical with predetermined activity profile
10/01/2002	US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002	US6458351 Yeast extracts
10/01/2002	CA2248047C Antagonism of endothelin actions
10/01/2002	CA2235943C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/01/2002	CA2174550C Suspension of loteprednol etabonate
10/01/2002	CA2123909C New combination of formoterol and budesonide
10/01/2002	CA2103546C Modified factor vii
10/01/2002	CA2069244C Drug-containing protein-bonded liposome
10/01/2002	CA2068632C Nanocrystalline magnetic iron oxide particles, processes for their preparation and their use in medical diagnostics and therapy
09/2002
09/30/2002	CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/27/2002	CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002	WO2002075304A1 Method of examining allergic disease
09/26/2002	WO2002074982A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states
09/26/2002	WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
09/26/2002	WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
09/26/2002	WO2002074913A2 Nucleic acid-associated proteins
09/26/2002	WO2002074911A2 Identification of gene expression alterations underlying the aging process in mammals
09/26/2002	WO2002074805A1 Soluble rage protein
09/26/2002	WO2002074769A1 Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
09/26/2002	WO2002074756A2 Urokinase inhibitors
09/26/2002	WO2002074348A1 Dry powder compositions comprising labelled particles for inhalation
09/26/2002	WO2002074346A2 Targeting chemical compounds to cells
09/26/2002	WO2002074343A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body
09/26/2002	WO2002074341A1 Antipruritics
09/26/2002	WO2002074337A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
09/26/2002	WO2002074335A2 Equine herpesvirus vaccine
09/26/2002	WO2002074328A1 Methods of treating respiratory conditions
09/26/2002	WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002	WO2002074314A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives
09/26/2002	WO2002074304A2 Composition containing a gallium (iii) complex and a therapeutically effective cytostatic agent
09/26/2002	WO2002074293A2 Methods for restoring cognitive function following systemic stress
09/26/2002	WO2002074292A2 Hormone replacement therapy
09/26/2002	WO2002074291A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
09/26/2002	WO2002074290A2 Dermatological preparations containing a nsaid
09/26/2002	WO2002074289A2 Antitumor compositions containing taxane derivatives
09/26/2002	WO2002074287A2 Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics

1 ... 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 ... 1151